SavedAdd your journal

Journals / Türk Patoloji Dergisi / 2022 / Cilt: 38 - Sayı: 2

The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition

John M. WRIGHT
Merva SOLUK TEKKESIN
Pages
168–184
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumors opened to online access in March 2022.
📊
Key Findings & Data:This edition is conceptually similar to the previous classification of odontogenic lesions.
💡
Conclusion & Impact:In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.
🔬Design:Review & Systematic Survey
📍Scope:2022 Verileri
⚙️Variables:Domain Parameters

Abstract

The 5th edition of the World Health Organization (WHO) Classification of Head and Neck Tumors opened to online access in March 2022. This edition is conceptually similar to the previous classification of odontogenic lesions. The only newly defined entity in odontogenic lesions is adenoid ameloblastoma, which is classified under benign epithelial odontogenic tumors. While not odontogenic, the surgical ciliated cyst is a new entry to the cyst classification of the jaws. In other respects, a very important change was made in the new blue books that added ‘essential and desirable diagnostic criteria’ for each entity to highlight the features considered indispensable for diagnosis. In this article, we review the odontogenic tumors and cysts of the jaw sections of the Odontogenic and Maxillofacial Bone Tumors Chapter, outlining changes from the 2017 WHO classification and summarizing the essential diagnostic criteria and new developments.

🔖

Cite This Article

WRIGHT, J. M., TEKKESIN, M. S. (2022). The World Health Organization Classification of Odontogenic Lesions: A Summary of the Changes of the 2022 (5th) Edition. Türk Patoloji Dergisi, Cilt: 38 - Sayı: 2, 168–184. https://ajindex.com/articles/640329

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. WHO Classification of Tumours Editorial Board. Head and neck tumours [Internet; beta version ahead of print]. Lyon (France): International Agency for Research on Cancer; 2022. (WHO classification of tumours series, 5th ed.; vol. 9). Available from:
  2. Vered M, Wright JM. Update from the 5th Edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol. 2022;16:63-75
  3. Soluk-Tekkeşin M, Wright JM. The World Health Organization classification of odontogenic lesions: A summary of the changes of the 2017 (4th) edition. Turk Patoloji Derg. 2018;34(1)
  4. Odontogenic and maxilofacial bone tumours. In: El-naggar ak, Chan JkC, Grandis Jr, Takata T, Slootweg P, editors. WHO classification of head and neck tumours. 4th ed. lyon: IARC; 2017. 205-60
  5. Loyola AM, Cardoso SV, de Faria PR, Servato JP, Eisenberg AL, Dias FL, Thavaraj S, Gomes CC, Gomez RS. Adenoid ameloblastoma: Clinicopathologic description of five cases and systematic review of the current knowledge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:368-77
  6. Vargas PA, Carlos-Bregni R, Mosqueda-Taylor A, Cuairan- Ruidíaz V, Lopes MA, de Almeida OP. Adenomatoid dentinoma or adenomatoid odontogenic hamartoma: What is the better term to denominate this uncommon odontogenic lesion? Oral Dis. 2006;12:200-3
  7. Mosqueda-Taylor A, Carlos-Bregni R, Ledesma-Montes C, Fillipi RZ, de Almeida OP, Vargas PA. Calcifying epithelial odontogenic tumor-like areas are common findings in adenomatoid odontogenic tumors and not a specific entity. Oral Oncol. 2005;41:214-5
  8. Coura BP, Bernardes VF, de Sousa SF, França JA, Pereira NB, Pontes HAR, Batista AC, da Cruz Perez DE, Albuquerque Junior RLC, de Souza LB, Martins MD, Diniz MG, Gomez RS, Gomes CC. KRAS mutations drive adenomatoid odontogenic tumor and are independent of clinicopathological features. Mod Pathol. 2019;32:799-806
  9. Zhou CX, Li TJ. A clinicopathologic study on central odontogenic fibroma: With special reference to amyloid variant. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126:513-20
  10. Philipsen HP, Reichart PA. Unicystic ameloblastoma. A review of 193 cases from the literature. Oral Oncol. 1998;34:317-25
  11. Heikinheimo K, Huhtala JM, Thiel A, Kurppa KJ, Heikinheimo H, Kovac M, Kragelund C, Warfvinge G, Dawson H, Elenius K, Ristimäki A, Baumhoer D, Morgan PR. The mutational profile of unicystic amel